Speaker, if you seek it, you will find unanimous consent to allow members to wear pins in recognition of June being ALS Awareness Month.

I did not.

Interjections.

I’m happy to look into the individual case. But I will say that Ontario has led Canadian provinces and territories. When Health Canada receives and gives approval for new drugs and new therapies, when it goes through the pCPA pricing process, and when there is an assessment on when the drugs are appropriately used in the population, Ontario actually leads Canada in getting it on the drug formulary and making sure that we have access here in Ontario.

The member opposite is inserting herself and her party into clinical decisions that should best be left to clinicians and to hospital leadership, and I will continue to let them lead.